Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

NCT00286494 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

493

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Alogliptin and pioglitazone
DRUG: Alogliptin and pioglitazone
DRUG: Pioglitazone

Sponsor

Takeda